Annual Results Press Conference 2022
Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.
Search
Code of Conduct
Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Metabolic Diseases
Metabolic Diseases
Across Cancer Types
Across Cancer Types
Taking Animal Health Forward: Industry experts share their view at NZVA & NZVNA Conference
24 June, Christchurch: The animal health sector needs to change to keep up with the times, according to the discussion at a breakfast event hosted by Boehringer Ingelheim at the NZVA and NZVNA Conference in Christchurch
TOP Employer 2023
TOP Employer 2023
The Angels Initiative Surpasses 1,000 Registrations for Acute Stroke Training
Global program equips HCPs for optimal acute stroke treatment
Early diagnosis and a positive outlook: Bill’s story
Early diagnosis and a positive outlook: Bill’s story
Putting a green spotlight on health
Boehringer Ingelheim’s new-generation reusable and propellant-free inhalers
Better healthcare access for vulnerable communities in New Zealand
working with our partners in New Zealand to bring affordable diabetes medicine to people who need it most—and that includes indigenous Māori and Pacific Islander communities